Clinical trial · Observational
Proteome- and Methylation Profiles in Oropharyngeal Cancer
NCT04567082CI-TRIAL-00076688PROMEOcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical study aims to evaluate proteome- and methylation profiles in saliva in patients with oropharyngeal cancers
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Oropharynx Cancer | Malignant Oropharyngeal Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Examination of saliva | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Cancer group
- interventionNames
- Diagnostic Test: Examination of saliva
- label
- Control group
- interventionNames
- Diagnostic Test: Examination of saliva
Primary outcomes (1)
- measure
- Differences in proteome and methylation profiles
- timeFrame
- At diagnosis
- description
- Differences between cancer- and control group
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Cancer group: Inclusion Criteria: * Written informed consent * Verified oropharyngeal squamous cell carcinoma Exclusion Criteria: * Other active cancer * Uncontrolled comorbidity * Unable to give informed consent Control group: Inclusion Criteria: * Written informed consent * Normal ENT examination Exclusion Criteria: * Active cancer * Uncontrolled comorbidity * Unable to give informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.